UrgoTouch’s® functionning
3 FACTORS WHICH DETERMINE THE QUALITY OF THE SCAR
The surgical technique and the surgeon’s suture
Controlled by the surgeon
Pre and post-operative care
Controlled by the patient
The biological healing process
UNCONTROLLED, but can be optimised by UrgoTouch®
Why is the scarring process result very unpredictable and random?
The scarring process takes place in 4 main phases (hemostasis, inflammation, proliferation and maturation) during all of which growth factors (proteins that stimulate the growth of specific tissues) play a key role in organizing the healing process and orchestrating the recovery of the skin. It notably instructs other types of cells to start the production of collagen.
In order to obtain a aesthetic and sufficiently elastic scar, the molecular concentration must be appropriately regulated to ensure a good balance between the synthesis of :
- Collagen Type I, which is thicker and more rigid, and thus essential to restore the extra-cellular matrix
- Collagen Type III, which also contributes to restoring the extra-cellular matrix, but is a lot thinner and flexible than – Collagene Type I, and hence essential to make the scar aesthetic and elastic.
If the mollecular concentration is not rightly balanced, the production of Collagen Type I seems to be too high compared to that of Collagene Type III, resulting in the scar being more fibrotic and less elastic and in an important risk of having an unaesthetic and problematic scars.
How does UrgoTouch optimize the scarring process?
UrgoTouch® is a laser technology that has demonstrated to optimize the scar result, which can be used on all skin phototypes (Types I to VI), and which only requires one single session in the operating room at the end of any body surgery.*
UrgoTouch’s efficiency has been demonstrated through various published clinical studies and cases and has proven to decrease the scars volume by up to 53%.**
By inducing a temperature of 50°C on the surface of the skin, right on the suture, UrgoTouch’s objective is to safely activate Heat shock protein HSP70, which aim is to protect skin cells from damages caused by overly high temperatures.
Recent experimental studies have clearly demonstrated that HSP70, which is over-expressed following laser irradiation, could play a role in the modulation of the inflammatory reponse. Thus, the regulation of the inflammatory activity may reduce the production of type I collagen as well as inflammatory molecules, leading thereby to improved healing results for patients.***
Studies have demonstrated that UrgoTouch® optimizes the appearance of scars by reducing the randomness and highly unpredictable outcomes in the healing process associated with this molecular pathway.
*Contraindication for face and cancer
**A 1 Year Follow-up of Post-operative Scars After the Use of a 1210nm Laser Assisted Skin Healing (LASH) Technology: A Randomized Controlled Trial. D.Casanova, ed. Aesthetic Plastic Surgery Journal. Feb 2017 – Reduction of 53% observed in a patient with dark phototype
***Mordon S, Capon A, et al. Lasers thermiques et cicatrisation cutanée. Med Sci (Paris). 2010 Jan